Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ironwel Injection
Ironwel Injection is a clinically proven intravenous iron therapy containing Iron Sucrose 100 mg, designed to rapidly replenish iron stores in patients with iron deficiency anemia (IDA). It is particularly beneficial for patients with chronic kidney disease (CKD), post-surgical blood loss, and anemia due to nutritional deficiencies.
Uses of Ironwel Injection
Ironwel Injection is indicated for the treatment of:
Iron Deficiency Anemia (IDA)
Anemia associated with Chronic Kidney Disease (CKD)
Postpartum or Post-Surgical Anemia
Anemia due to Heavy Menstrual Bleeding
Iron Deficiency in Patients on Hemodialysis
Benefits of Ironwel Injection
Rapid & Effective Iron Replenishment
Improves Hemoglobin & Red Blood Cell Production
Well-Tolerated with a Lower Risk of Hypersensitivity
Suitable for CKD & Dialysis Patients
Enhances Energy Levels & Reduces Fatigue
Mechanism of Action of Ironwel Injection
Iron Sucrose is absorbed by reticuloendothelial cells, where it is gradually released to transferrin, facilitating hemoglobin synthesis and erythropoiesis. This ensures a steady and controlled iron supply, reducing the risk of iron overload and toxicity.